Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021

Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia’s routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associate...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Abyot Bekele Woyessa, Monica P. Shah, Binyam Moges Azmeraye, Jeff Pan, Leuel Lisanwork, Getnet Yimer, Shu-Hua Wang, J. Pekka Nuorti, Miia Artama, Almea M. Matanock, Qian An, Paulos Samuel, Bekana Tolera, Birhanu Kenate, Abebe Bekele, Tesfaye Deti, Getachew Wako, Amsalu Shiferaw, Yohannes Lakew Tefera, Melkamu Ayalew Kokebie, Tatek Bogale Anbessie, Habtamu Teklie Wubie, Aaron Wallace, Ciara E. Sugerman
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2024-07-01
Reeks:	Vaccines
Onderwerpen:	measles measles-containing vaccine MCV1 MCV2 second year of life immunization coverage
Online toegang:	https://www.mdpi.com/2076-393X/12/7/762
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!